Skip to main content
    D

    DBV Technologies (DBVT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.27
    -0.74 (-6.76%)

    Market Cap: $692.19M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    DBV Technologies (DBVT) Financials: Revenue, Profit and Cash Flow

    Updated Oct 28, 2026. Financial statements from company filings, amounts in EUR.

    DBV Technologies reported revenue of EUR 0 for the fiscal year ended Dec 31, 2025, down 100.0% from the year before. That year, net income was EUR -146.95M, operating cash flow was EUR -121.18M and free cash flow was EUR -121.71M. The quarter ended Sep 30, 2026 had revenue of EUR 0 and net income of EUR -64.50M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of EUR 147.06M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 20250-100.0%N/AN/AN/A
    Dec 20242.57M-83.7%-265.3%-4693.4%-4428.2%
    Dec 202315.73M+224.7%100.0%-486.0%-462.4%
    Dec 20224.84M-15.1%100.0%-1994.9%-1987.5%
    Dec 20215.71M-49.4%-82.0%-1727.6%-1713.5%
    Dec 202011.28M-23.3%100.0%-1408.7%-1415.0%
    Dec 201914.71M+14.8%100.0%-1162.8%-1169.5%
    Dec 201812.81M+11.3%100.0%-1483.6%-1484.7%
    Dec 201711.52M+45.3%100.0%-1510.0%-1538.3%
    Dec 20167.93MN/A100.0%-1540.6%-1593.9%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue02.57M15.73M4.84M5.71M11.28M14.71M12.81M11.52M7.93M
    Cost of revenue17.67M6.81M-4.50M20.30M10.39M17.49M3.09M5.03M3.43M1.42M
    Gross profit-17.67M-6.81M15.73M4.84M-4.68M11.28M14.71M12.81M11.52M7.93M
    Research and development116.68M89.90M60.22M75.54M70.34M101.61M112.24M123.50M126.25M82.90M
    Operating income-147.06M-120.53M-76.43M-96.63M-98.61M-158.84M-171.02M-190.12M-173.94M-122.13M
    Net income-146.95M-113.72M-72.73M-96.27M-97.81M-159.56M-172.01M-190.26M-177.20M-126.35M
    EBITDA-143.86M-110.99M-63.27M-83.47M-91.16M-124.83M-168.43M-186.64M-170.06M-120.25M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue000000511.00K01.07M1.16M1.41M8.88M
    Gross profitN/AN/A-4.22M-4.28M-4.28M-4.62M511.00KN/A1.07M-4.15M1.41M8.88M
    Operating income-64.80M-51.30M-47.90M-45.05M-36.89M-43.11M-26.62M-23.86M-30.33M-34.97M-28.56M-11.92M
    Net income-64.50M-50.40M-47.60M-44.83M-33.02M-42.40M-27.08M-23.02M-30.44M-33.09M-27.34M-11.19M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded short-term debt of EUR 16.27M by 177.89M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets233.72M65.66M182.99M246.52M146.32M272.25M271.73M234.76M250.28M317.16M
    Current assets212.94M44.39M158.91M223.07M114.52M207.37M204.55M198.83M220.81M300.26M
    Cash and equivalents194.17M32.46M141.37M209.19M77.30M196.35M193.25M167.81M194.08M282.93M
    Total liabilities64.95M38.27M42.80M52.06M47.29M66.75M78.54M68.98M67.40M49.26M
    Short-term debt16.27M1.50M2.03M8.90M3.51M4.43M4.33MN/AN/AN/A
    Long-term debtN/AN/AN/AN/AN/A543.00K721.00K1.28M1.82M4.05M
    Shareholder equity168.77M27.39M140.19M194.45M99.03M205.49M193.19M165.78M182.88M267.90M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets215.40M223.20M266.40M233.72M110.50M143.43M50.56M65.66M93.06M114.19M145.90M182.99M
    Total liabilities66.70M62.80M58.50M64.95M57.64M57.20M47.69M38.27M39.02M35.09M34.24M42.80M
    Cash and equivalents165.70M174.90M229.20M194.17M69.84M103.21M12.96M32.46M46.44M66.21M101.53M141.37M
    Shareholder equity148.60M160.40M207.90M168.77M52.85M86.22M2.87M27.39M54.03M79.09M111.65M140.19M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-121.18M-104.47M-79.65M-55.70M-108.24M-165.61M-148.35M-186.74M-160.91M-65.68M
    Capital expenditures533.64K2.34M677.00K754.00K918.00K2.76M5.60MN/A10.62MN/A
    Free cash flow-121.71M-106.81M-80.33M-56.45M-109.16M-168.37M-153.94MN/A-171.53MN/A
    Dividends paidN/AN/AN/AN/AN/A303.00K0000
    Investing cash flow-1.37M-757.00K-808.00K-100.00K-433.00K-2.87M-5.66M-11.81M-11.03MN/A
    Financing cash flow276.18M587.00K6.77M194.10M274.00K149.55M207.58M178.62MN/AN/A
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-51.50M-83.08M-49.10M-35.17M-32.44M-33.91M-19.67M-12.25M-22.46M-35.07M-34.69M-13.69M
    Capital expenditures42.00K10.00K400.00K373.00K117.00K32.00K10.00K125.00K396.00K732.00K1.33M352.00K
    Free cash flow-51.54M-83.09M-49.50M-35.55M-32.55M-33.94M-19.68M-12.38M-22.85M-35.80M-36.03M-14.04M
    Last 12 quarters

    Frequently Asked Questions About DBVT

    What is DBV Technologies' annual revenue?

    DBV Technologies reported revenue of EUR 0 for the fiscal year ended Dec 31, 2025.

    How fast is DBV Technologies' revenue growing?

    Revenue was down 100.0% for the fiscal year ended Dec 31, 2025 compared with the year before.

    Is DBV Technologies profitable?

    No. DBV Technologies reported net income of EUR -146.95M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does DBVT generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of EUR -121.18M minus capital expenditures of EUR 533.64K produced free cash flow of EUR -121.71M.

    How much debt does DBV Technologies have?

    The balance sheet dated Dec 31, 2025 reported short-term debt of EUR 16.27M and cash and equivalents of EUR 194.17M.